Gregory Wasson
About Gregory Wasson
Independent director since July 2020; age 66. Former President and CEO of Walgreens (2009–2015) and Walgreens Boots Alliance, Inc. (2015), now President and Co‑founder of Wasson Enterprise (since 2016). He served as Executive Chairman of Innovation Associates (iA) from November 2019 to December 2024 and is Chairman and co‑founder of Cooler Screens (since 2017). Current public company directorship: P3 Health Partners Inc.; prior boards include PNC Financial Services Group (2015–2018) and Verizon Communications (2013–2018) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Walgreens | President & CEO | 2009–2015 | Led large-scale retail operations and healthcare strategy |
| Walgreens Boots Alliance, Inc. | President & CEO | 2015 | Oversaw integration and leadership of combined enterprise |
| Walgreens | President & COO | 2007–2009 | Senior operating leadership |
| Walgreen Health Services | President & EVP | 2001–2006 | Healthcare services leadership |
| Walgreens | VP Store Operations | 1999–2001 | Retail operations management |
| Walgreens | District Manager | 1986–1999 | Field leadership |
| Walgreens | Pharmacy Technician, Pharmacist, Store Manager | 1981–1986 | Early-career pharmacy and store leadership |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Wasson Enterprise | President & Co‑founder | 2016–present | Family office building high‑growth businesses |
| Innovation Associates (iA) | Executive Chairman | 2019–2024 | Pharmacy automation leader |
| Cooler Screens, Inc. | Co‑founder & Chairman | 2017–present | Retail media platform at point of sale |
| P3 Health Partners Inc. | Director | current | Public, population health management |
| Foresight Acquisition Corp. | Chairperson | 2020–2021 | SPAC predecessor to P3; governance leadership |
| Reliefband; Performance Health Systems | Director | current | Privately held companies |
| PNC Financial Services Group | Director | 2015–2018 | Prior public board |
| Verizon Communications | Director | 2013–2018 | Prior public board |
Board Governance
- Independence: Board determined all current directors (including Wasson) are independent under Nasdaq; committees composed entirely of independent directors .
- Chairperson: Independent chair (Lynn O’Connor Vos) and independent director executive sessions occur regularly .
- Attendance: In 2024, Board held 16 meetings; each incumbent director attended at least 75% of board and committee meetings; all directors attended last year’s annual meeting .
| Committee | Role (Wasson) | 2024 Meetings | Notes |
|---|---|---|---|
| Compensation Committee | Member | 3 | Chair: James Lang; remit includes CEO pay, executive pay, plans, clawback, ownership guidelines |
| Audit Committee | Not a member | 12 | Chair: Patrick Spangler; responsibilities include auditor oversight, financial reporting, cyber risk, related party reviews |
| Nominating & Governance Committee | Not a member | 3 | Chair: Catherine Klema; board composition, ESG oversight, governance guidelines |
Fixed Compensation
| Component | Amount ($) | Notes |
|---|---|---|
| Fees Earned or Paid in Cash (2024) | 45,000 | Actual cash received for 2024 |
| Program – Annual Cash Retainer | 40,000 | Standard cash retainer for non‑employee directors |
| Program – Compensation Committee Member | 5,000 | Incremental annual retainer per Compensation Committee member |
| Program – Chair fees (not applicable to Wasson) | 10,000 (Comp Chair); 20,000 (Audit Chair); 8,000 (N&G Chair) | For chair roles; Wasson is not a chair |
Performance Compensation
| Equity Award | Grant Date Value ($) | Units/Status | Vesting |
|---|---|---|---|
| Annual RSU grant (2024) | 149,999 | RSUs; number not disclosed in table | Not disclosed |
| Unvested RSUs (as of 12/31/2024) | — | 13,286 units | Time‑based RSUs outstanding |
| Ownership Guidelines – Directors | — | 3x annual cash retainer; retention of 50% of net shares until compliant | Must comply within 5 years of election or 6/22/2021 |
Compensation mix signal: Equity comprised ~77% of Wasson’s 2024 director pay ($149,999 equity vs. $45,000 cash), aligning incentives with shareholders .
Other Directorships & Interlocks
| Company | Role | Tenure | Potential Interlock/Conflict |
|---|---|---|---|
| P3 Health Partners Inc. | Director | current | No related‑party transactions disclosed by OPRX; independence affirmed |
| Cooler Screens, Reliefband, Performance Health Systems | Director/Chair | current | Private companies; no OPRX related‑party exposure disclosed |
| PNC Financial Services Group; Verizon Communications | Director (prior) | 2013–2018; 2015–2018 | Prior roles; no current interlocks |
Expertise & Qualifications
- Board skill matrix indicates Wasson contributes capabilities in risk management, healthcare industry, digital healthcare technology, other public company board experience, corporate governance, executive compensation, and human capital management .
Equity Ownership
| Holder | Shares Beneficially Owned | Percent of Outstanding | Notes |
|---|---|---|---|
| Gregory Wasson | 47,315 | <1% | Includes 13,286 RSUs vesting within 60 days of record date; shares outstanding were 18,493,447 |
Insider Trades (Form 4)
| Filing Date | Transaction Date | Type | Shares | Notes/Link |
|---|---|---|---|---|
| 2024-06-11 | 2024-06-05 | RSU grant (one‑for‑one) | N/A | SEC Form 4 indicates RSU grant; earliest transaction date 06/05/2024 |
| 2025-06-12 | 2025-06-11 | RSU grant | N/A | Company site lists Wasson Form 4 filing (PDF) |
Related Party Transactions and Conflicts
- Audit Committee reviews related party transactions; Board’s independence review found no transactions or relationships that would compromise independence for Wasson .
- Corporate policies prohibit short sales, hedging, margin accounts, and pledging, reducing alignment risk .
Governance Assessment
- Strengths: Independent director; equity‑heavy director pay; compliance with director stock ownership guidelines or time remaining to comply; strong board governance practices (independent chair; executive sessions; overboarding limits) .
- Engagement: Attended ≥75% of Board/committee meetings in 2024; Board met 16 times; his committee met 3 times; attended last annual meeting .
- RED FLAGS: SEC administrative order (Walgreens, 2018) resolved with Wasson agreeing to a $160,000 civil penalty and cease‑and‑desist; while historical and unrelated to OPRX operations, it is a governance blemish to monitor for disclosure and potential investor perception impact .
- Compensation Committee role: As member, influences CEO and executive pay, clawback, ownership guidelines, and succession planning; Compensation Committee uses independent consultant (Pearl Meyer) and assessed consultant independence, which supports governance quality .
Overall, Wasson brings deep healthcare retail and operational experience, public board seasoning, and alignment via equity grants. Independence and attendance are satisfactory, with no OPRX related‑party issues disclosed; continued transparency around past SEC matter and adherence to anti‑hedging/pledging policies mitigate governance concerns .